Abstract
In spite of the high incidence of breast cancer, there are few pharmacological strategies available to prevent the development of tumors and recurrences in the high risk population. The available strategies are used systemically and provoke severe adverse effects, like fatigue, reduction of bone density, thromboembolism, cardiovascular symptoms and increased risk of developing other tumor…